IONS

HOUGEN ELIZABETH L

Known title: EVP, Finance & CFOCIK: 0001074773

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

Cathie Wood adds to Ionis position amid RNA sector interest. Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.

this person other insiders at IONS

Transaction History

IONS▼ Sell$745K
IONS▲ Buy$3.7M
IONS▲ Buy$3.5M
IONS▲ Buy$1.1M
IONS▲ Buy$772K
IONS▼ Sell$14.9M
IONS▼ Sell$687K
IONS▼ Sell$582K
IONS▲ Buy$0
IONS▼ Sell$972K
IONS▲ Buy$0
IONS▲ Buy$2.7M
IONS▼ Sell$3.2M
IONS▼ Sell$49K
IONS▲ Buy$0
IONS▼ Sell$291K
IONS▲ Buy$0
IONS▼ Sell$105K
IONS▲ Buy$0
IONS▼ Sell$438K
IONS▲ Buy$0
IONS▲ Buy$2.1M
IONS▼ Sell$2.2M
IONS▼ Sell$5K
IONS▼ Sell$84K
IONS▲ Buy$0
IONS▼ Sell$329K
IONS▲ Buy$0
IONS▼ Sell$6K
IONS▼ Sell$11K
IONS▲ Buy$0
IONS▼ Sell$236K

We use analytics to understand how market-wall is used. No personal data is sold.